Molecular phylogenetics and species-level systematics of Baylisascaris

por Camp, Lauren E., Radke, Marc R., Shihabi, Danny M., Pagan, Christopher, Yang, Guangyou, Nadler, Steven A.
Publicado 2018

Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation

por Sullivan, Meghan R., Prakash, Rohit, Rawal, Yashpal, Wang, Weibin, Sung, Patrick, Radke, Marc R., Kaufmann, Scott H., Swisher, Elizabeth M., Bernstein, Kara A., Jasin, Maria
Publicado 2021

Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple negative breast and ovarian carcinomas

por Menghi, Francesca, Banda, Kalyan, Kumar, Pooja, Straub, Robert, Dobrolecki, Lacey, Rodriguez, Isabel V., Yost, Susan E., Chandok, Harshpreet, Radke, Marc R., Somlo, George, Yuan, Yuan, Lewis, Michael T., Swisher, Elizabeth M., Liu, Edison T.
Publicado 2022

BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance

por Wang, Yifan, Bernhardy, Andrea J., Nacson, Joseph, Krais, John J., Tan, Yin-Fei, Nicolas, Emmanuelle, Radke, Marc R., Handorf, Elizabeth, Llop-Guevara, Alba, Balmaña, Judith, Swisher, Elizabeth M., Serra, Violeta, Peri, Suraj, Johnson, Neil
Publicado 2019

Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer

por Ghezelayagh, Talayeh S., Kohrn, Brendan F., Fredrickson, Jeanne, Manhardt, Enna, Radke, Marc R., Katz, Ronit, Gray, Heidi J., Urban, Renata R., Pennington, Kathryn P., Liao, John B., Doll, Kemi M., Simons, Elise J., Burzawa, Jennifer K., Goff, Barbara A., Speiser, Paul, Swisher, Elizabeth M., Norquist, Barbara M., Risques, Rosa Ana
Publicado 2022

Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants

por Prakash, Rohit, Rawal, Yashpal, Sullivan, Meghan R., Grundy, McKenzie K., Bret, Hélène, Mihalevic, Michael J., Rein, Hayley L., Baird, Jared M., Darrah, Kristie, Zhang, Fang, Wang, Raymond, Traina, Tiffany A., Radke, Marc R., Kaufmann, Scott H., Swisher, Elizabeth M., Guérois, Raphaël, Modesti, Mauro, Sung, Patrick, Jasin, Maria, Bernstein, Kara A.
Publicado 2022

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

por Ho, Gwo Yaw, Vandenberg, Cassandra J., Lim, Ratana, Christie, Elizabeth L., Garsed, Dale W., Lieschke, Elizabeth, Nesic, Ksenija, Kondrashova, Olga, Ratnayake, Gayanie, Radke, Marc, Penington, Jocelyn S., Carmagnac, Amandine, Heong, Valerie, Kyran, Elizabeth L., Zhang, Fan, Traficante, Nadia, Huang, Ruby, Dobrovic, Alexander, Swisher, Elizabeth M., McNally, Orla, Kee, Damien, Wakefield, Matthew J., Papenfuss, Anthony T., Bowtell, David D. L., Barker, Holly E., Scott, Clare L.
Publicado 2023

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

por Kim, Joseph W., McKay, Rana R., Radke, Marc R., Zhao, Shilin, Taplin, Mary-Ellen, Davis, Nancy B., Monk, Paul, Appleman, Leonard J., Lara, Primo N., Vaishampayan, Ulka N., Zhang, Jingsong, Paul, Asit K., Bubley, Glenn, Van Allen, Eliezer M., Unlu, Serhan, Huang, Ying, Loda, Massimo, Shapiro, Geoffrey I., Glazer, Peter M., LoRusso, Patricia M., Ivy, S. Percy, Shyr, Yu, Swisher, Elizabeth M., Petrylak, Daniel P.
Publicado 2023

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

por Nesic, Ksenija, Krais, John J., Vandenberg, Cassandra J., Wang, Yifan, Patel, Pooja, Cai, Kathy Q., Kwan, Tanya, Lieschke, Elizabeth, Ho, Gwo-Yaw, Barker, Holly E., Bedo, Justin, Casadei, Silvia, Farrell, Andrew, Radke, Marc, Shield-Artin, Kristy, Penington, Jocelyn S., Geissler, Franziska, Kyran, Elizabeth, Zhang, Fan, Dobrovic, Alexander, Olesen, Inger, Kristeleit, Rebecca, Oza, Amit, Ratnayake, Gayanie, Traficante, Nadia, DeFazio, Anna, Bowtell, David D. L., Harding, Thomas C., Lin, Kevin, Swisher, Elizabeth M., Kondrashova, Olga, Scott, Clare L., Johnson, Neil, Wakefield, Matthew J.
Publicado 2023

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

por Hurley, Rachel M, McGehee, Cordelia D, Nesic, Ksenija, Correia, Cristina, Weiskittel, Taylor M, Kelly, Rebecca L, Venkatachalam, Annapoorna, Hou, Xiaonan, Pathoulas, Nicholas M, Meng, X Wei, Kondrashova, Olga, Radke, Marc R, Schneider, Paula A, Flatten, Karen S, Peterson, Kevin L, Becker, Marc A, Wong, Ee Ming, Southey, Melissa S, Dobrovic, Alexander, Lin, Kevin K, Harding, Thomas C, McNeish, Iain, Ross, Christian A, Wagner, Jill M, Wakefield, Matthew J, Scott, Clare L, Haluska, Paul, Wahner Hendrickson, Andrea E, Karnitz, Larry M, Swisher, Elizabeth M, Li, Hu, Weroha, S John, Kaufmann, Scott H
Publicado 2021